NPS

Experts to examine latest scientific research in the field of new drugs

Novel (or new) psychoactive substances (NPS) are an ever-increasing group of synthetic, semi-synthetic or natural compounds, often advertised and sold as ‘legal’ alternatives to illicit drugs. Often misrepresented as ‘safe’ for recreational...

G8 statement of intent on collecting and sharing of data on new drugs

New psychoactive substances (NPS) have changed the nature of the global drugs market. Substances that are not under international control, but mimic the effects of controlled substances, are now widely available. NPS...

Over 100 specialists from across the globe to review international developments in new drugs field

Leading European and international specialists will meet in Lisbon from 27–28 June to take stock of the global new drugs phenomenon. The Third international multidisciplinary forum on new drugs, organised by the...

New drugs cause fundamental shift in Europe’s drug market

The number, type and availability of new drugs in Europe continued to increase in 2012, according to a report released today by the EMCDDA and Europol (1). Driven by globalisation, technological advancement...

New drug 4-MA to be placed under control across the EU

Europe has responded today to concerns over the use of the stimulant drug 4-methylamphetamine (4-MA) by subjecting it to ‘control measures and criminal penalties’ throughout the Union. The Decision of the Council...

EMCDDA welcomes European Commission call for stronger EU action on new drugs

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of...

New drugs detected in the EU at the rate of around one per week, say agencies

New drugs were detected in the European Union last year at the rate of around one per week, according to the EMCDDA–Europol 2011 annual report on new psychoactive substances released today (1)...

First international multidisciplinary forum on new drugs, 11–12 May 2011, Lisbon

Leading European and international experts on new drugs met in Lisbon from 11–12 May at the First international multidisciplinary forum on new drugs, organised by the EU drugs agency (EMCDDA). The participating...

New drugs becoming available at ‘unprecedented pace’, says report

New psychoactive substances are becoming widely available at an ‘unprecedented pace’. This is according to the EMCDDA–Europol 2010 annual report on new drugs entering the European market released today in Lisbon (1)...

Council calls on EU scientific experts to assess risks of mephedrone

Europe has responded to rising concern over the use of the synthetic drug mephedrone by formally requesting a scientific investigation into the health and social risks of the substance. The decision was...

Subscribe to NPS